Related Experiment Video
Updated: Jul 2, 2026

Visualizing Non-lytic Exocytosis of Cryptococcus neoformans from Macrophages Using Digital Light Microscopy
Published on: October 21, 2014
Arginase 1 Expression by Macrophages Promotes Cryptococcus neoformans Proliferation and Invasion into Brain
Adithap Hansakon1,2, Chumpol Ngamphiw3, Sissades Tongsima3
1Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathum Thani, Thailand.
Abstract:
Cryptococcal meningoencephalitis caused by Cryptococcus neoformans infection is the most common cause of death in HIV/AIDS patients. Macrophages are pivotal for the regulation of immune responses to cryptococcal infection by either playing protective function or facilitating fungal dissemination. However, the mechanisms underlying macrophage responses to C. neoformans remain unclear. To analyze the transcriptomic changes and identify the pathogenic factors of macrophages, we performed a comparative transcriptomic analysis of alveolar macrophage responses during C. neoformans infection. Alveolar macrophages isolated from C. neoformans-infected mice showed dynamic gene expression patterns, with expression change from a protective M1 (classically activated)-like to a pathogenic M2 (alternatively activated)-like phenotype. Arg1, the gene encoding the enzyme arginase 1, was found as the most upregulated gene in alveolar macrophages during the chronic infection phase. The in vitro inhibition of arginase activity resulted in a reduction of cryptococcal phagocytosis, intracellular growth, and proliferation, coupled with an altered macrophage response from pathogenic M2 to a protective M1 phenotype. In an in vitro model of the blood-brain barrier, macrophage-derived arginase was found to be required for C. neoformans invasion of brain microvascular endothelium. Further analysis of the degree of virulence indicated a positive correlation between arginase 1 expression in macrophages and cryptococcal brain dissemination in vivo. Thus, our data suggest that a dynamic macrophage activation that involves arginase expression may contribute to the cryptococcal disease by promoting cryptococcal growth, proliferation, and the invasion to the brain endothelium.
Insights
Arginase 1 in macrophages promotes Cryptococcus neoformans growth and brain invasion, contributing to cryptococcal meningoencephalitis in HIV/AIDS patients. Inhibiting arginase shifts macrophages to a protective state, reducing fungal burden.
Area of Science:
- Immunology
- Mycology
- Neuroscience
Background:
- Cryptococcal meningoencephalitis is a leading cause of death in HIV/AIDS patients.
- Macrophages play a dual role in cryptococcal infections, either protecting or facilitating fungal spread.
- Mechanisms of macrophage response to Cryptococcus neoformans are not fully understood.
Purpose of the Study:
- To investigate transcriptomic changes in macrophages during C. neoformans infection.
- To identify pathogenic factors involved in macrophage responses.
- To elucidate the role of arginase 1 in cryptococcal pathogenesis and brain dissemination.
Main Methods:
- Comparative transcriptomic analysis of alveolar macrophages from C. neoformans-infected mice.
- In vitro inhibition of arginase activity.
- In vitro blood-brain barrier model to assess C. neoformans invasion.
- In vivo correlation of arginase 1 expression and fungal brain dissemination.
Main Results:
- Macrophage gene expression shifted from a protective M1-like to a pathogenic M2-like phenotype during infection.
- Arginase 1 (Arg1) was the most upregulated gene in macrophages during chronic infection.
- Inhibiting arginase reduced fungal phagocytosis, intracellular growth, and proliferation, and shifted macrophages to an M1 phenotype.
- Macrophage-derived arginase was essential for C. neoformans invasion of brain endothelium.
- A positive correlation was observed between arginase 1 expression and fungal brain dissemination.
Conclusions:
- Dynamic macrophage activation involving arginase expression contributes to cryptococcal disease.
- Arginase promotes fungal growth, proliferation, and brain endothelium invasion.
- Targeting arginase may offer a therapeutic strategy for cryptococcal infections, particularly in HIV/AIDS patients.

